Roddy R E, Zekeng L, Ryan K A, Tamoufé U, Weir S S, Wong E L
Epidemiology Unit, Family Health International, Durham, NC 27709, USA.
N Engl J Med. 1998 Aug 20;339(8):504-10. doi: 10.1056/NEJM199808203390803.
Nonoxynol 9 is a proved spermicide, but whether it is also a microbicide is uncertain. A truly effective vaginal microbicide would reduce the susceptibility of women to sexually transmitted diseases, including infection with the human immunodeficiency virus (HIV).
We enrolled 1292 HIV-negative female sex workers in Cameroon and enrolled them in a double-blind, placebo-controlled study in which the participants were randomly assigned to use either a film containing 70 mg of nonoxynol 9 or a placebo film, inserted into the vagina before intercourse. All of the women were provided with latex condoms and were instructed to have their male sexual partners use them. At monthly follow-up visits, we examined the women with a colposcope for genital lesions, tested endocervical specimens for gonorrhea and chlamydia infection with DNA probes, tested for HIV infection, and treated the women for curable sexually transmitted diseases.
The rates of HIV infection (cases per 100 woman-years) were 6.7 in the nonoxynol 9 group and 6.6 in the placebo group (rate ratio, 1.0; 95 percent confidence interval, 0.7 to 1.5). The rates of genital lesions were 42.2 cases per 100 woman-years in the nonoxynol 9 group and 33.5 in the placebo group (rate ratio, 1.3; 95 percent confidence interval, 1.0 to 1.6). The rates of gonorrhea were 33.3 and 31.1 cases per 100 woman-years in the nonoxynol 9 and placebo groups, respectively (rate ratio, 1.1; 95 percent confidence interval, 0.8 to 1.4). The corresponding rates of chlamydia infection in the nonoxynol 9 group and the placebo group were 20.6 and 22.2 per 100 woman-years (rate ratio, 0.9; 95 percent confidence interval, 0.7 to 1.3). The women reported that condoms were used during 90 percent of sexual acts.
The use of a nonoxynol 9 vaginal film did not reduce the rate of new HIV, gonorrhea, or chlamydia infection in this group of sex workers who used condoms and received treatment for sexually transmitted diseases.
壬苯醇醚9是一种已证实的杀精剂,但它是否也是一种杀菌剂尚不确定。一种真正有效的阴道杀菌剂将降低女性感染性传播疾病的易感性,包括感染人类免疫缺陷病毒(HIV)。
我们在喀麦隆招募了1292名HIV阴性的女性性工作者,并将她们纳入一项双盲、安慰剂对照研究,参与者被随机分配使用含有70毫克壬苯醇醚9的薄膜或安慰剂薄膜,在性交前插入阴道。所有女性都被提供了乳胶避孕套,并被指示让她们的男性性伴侣使用。在每月的随访中,我们用阴道镜检查女性的生殖器病变,用DNA探针检测宫颈标本中的淋病和衣原体感染,检测HIV感染,并对女性可治愈的性传播疾病进行治疗。
壬苯醇醚9组的HIV感染率(每100女性年的病例数)为6.7,安慰剂组为6.6(率比,1.0;95%置信区间,0.7至1.5)。壬苯醇醚9组的生殖器病变率为每100女性年42.2例,安慰剂组为33.5例(率比,1.3;95%置信区间,1.0至1.6)。壬苯醇醚9组和安慰剂组的淋病率分别为每100女性年33.3例和31.1例(率比,1.1;95%置信区间,0.8至1.4)。壬苯醇醚9组和安慰剂组衣原体感染的相应率分别为每100女性年20.6例和22.2例(率比,0.9;95%置信区间,0.7至1.3)。女性报告说,90%的性行为中使用了避孕套。
在这组使用避孕套并接受性传播疾病治疗的性工作者中,使用壬苯醇醚9阴道薄膜并没有降低新的HIV、淋病或衣原体感染率。